SEER
Seer, Inc. [SEER] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SEER Stock Summary
Top 10 Correlated ETFs
SEER
Top 10 Correlated Stocks
SEER
In the News
SEER Financial details
Company Rating
Neutral
Market Cap
119.18M
Income
-82.79M
Revenue
15.18M
Book val./share
6.19
Cash/share
4.93
Dividend
-
Dividend %
-
Employees
147
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-1.43
Forward P/E
-
PEG
1.69
P/S
8.16
P/B
0.3
P/C
0.34
P/FCF
-1.65
Quick Ratio
27.08
Current Ratio
27.65
Debt / Equity
0.07
LT Debt / Equity
0.07
-
-
EPS (TTM)
-1.3
EPS next Y
-
EPS next Q
-
EPS this Y
-4.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
39.02%
Revenue last 5Y
204.5%
Revenue Q/Q
9.6%
EPS Q/Q
-15.15%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
54.98%
Inst Trans
0.86%
ROA
-19%
ROE
-20%
ROC
-0.25%
Gross Margin
49%
Oper. Margin
-715%
Profit Margin
-570%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.455-5.65
52W High
-66.6%
52W Low
+67%
RSI
43
Rel Volume
1.03
Avg Volume
435.84K
Volume
448.05K
Perf Week
-3.47%
Perf Month
-20.1%
Perf Quarter
-1.18%
Perf Half Y
-16.5%
-
-
-
-
Beta
1.652
-
-
Volatility
0.05%, 0.09%
Prev Close
-4.57%
Price
1.67
Change
-0.6%
SEER Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.01 | 0.11 | 0.24 | 0.24 | |
| Net income per share | -0.26 | -0.51 | -1.13 | -1.42 | -1.35 | |
| Operating cash flow per share | -0.21 | -0.34 | -0.76 | -0.97 | -0.93 | |
| Free cash flow per share | -0.28 | -0.42 | -0.88 | -1.14 | -1.04 | |
| Cash per share | 1.41 | 7.09 | 6.57 | 6.75 | 4.95 | |
| Book value per share | 1.44 | 7.09 | 8.26 | 7.16 | 6.22 | |
| Tangible book value per share | 1.44 | 7.09 | 8.26 | 7.16 | 6.22 | |
| Share holders equity per share | 1.44 | 7.09 | 8.26 | 7.16 | 6.22 | |
| Interest debt per share | 0 | 0.09 | 0.38 | 0.48 | 0.44 | |
| Market cap | 3.44B | 3.42B | 1.39B | 362.11M | 123.87M | |
| Enterprise value | 3.42B | 3.09B | 1.18B | 338.78M | 119.63M | |
| P/E ratio | -214.36 | -109.71 | -20.23 | -4.08 | -1.44 | |
| Price to sales ratio | 59.29K | 5.21K | 217.13 | 24.66 | 8.16 | |
| POCF ratio | -263.06 | -164.18 | -29.95 | -5.96 | -2.1 | |
| PFCF ratio | -199.9 | -134.83 | -26.06 | -5.1 | -1.87 | |
| P/B Ratio | 39.22 | 7.92 | 2.76 | 0.81 | 0.31 | |
| PTB ratio | 39.22 | 7.92 | 2.76 | 0.81 | 0.31 | |
| EV to sales | 58.99K | 4.7K | 184.36 | 23.07 | 7.88 | |
| Enterprise value over EBITDA | -223.16 | -94.18 | -16.57 | -3.64 | -1.2 | |
| EV to operating cash flow | -261.73 | -148.16 | -25.43 | -5.57 | -2.03 | |
| EV to free cash flow | -198.88 | -121.68 | -22.13 | -4.77 | -1.8 | |
| Earnings yield | 0 | -0.01 | -0.05 | -0.24 | -0.7 | |
| Free cash flow yield | -0.01 | -0.01 | -0.04 | -0.2 | -0.54 | |
| Debt to equity | 0 | 0.01 | 0.05 | 0.07 | 0.07 | |
| Debt to assets | 0 | 0.01 | 0.04 | 0.06 | 0.06 | |
| Net debt to EBITDA | 1.14 | 10.18 | 2.94 | 0.25 | 0.04 | |
| Current ratio | 22.75 | 53.51 | 30.67 | 34.57 | 25 | |
| Interest coverage | -3.38K | -3.74K | -3.25K | -297.35 | 0 | |
| Income quality | 0.82 | 0.64 | 0.65 | 0.65 | 0.68 | |
| Dividend Yield | 0.02 | 0 | 0 | 0 | 0 | |
| Payout ratio | -4.51 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 79.41 | 23.42 | 0 | 0 | 0 | |
| Research and developement to revenue | 213.67 | 28.88 | 4.55 | 3.12 | 3.12 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.32 | 0.22 | 0.15 | 0.17 | 0.12 | |
| Capex to revenue | -71.22 | -6.91 | -1.08 | -0.7 | -0.48 | |
| Capex to depreciation | -5.89 | -2.82 | -2.71 | -2.6 | -1.31 | |
| Stock based compensation to revenue | 26.84 | 11.2 | 4.05 | 2.29 | 2.27 | |
| Graham number | 2.92 | 9.03 | 14.48 | 15.13 | 13.75 | |
| ROIC | -0.19 | -0.07 | -0.13 | -0.18 | -0.23 | |
| Return on tangible assets | -0.17 | -0.07 | -0.13 | -0.18 | -0.2 | |
| Graham Net | 1.33 | 6.92 | 6.06 | 6.21 | 4.45 | |
| Working capital | 82.99M | 425.03M | 398.28M | 422.4M | 317.29M | |
| Tangible asset value | 87.68M | 431.61M | 502.92M | 446.99M | 396.9M | |
| Net current asset value | 81.25M | 422.42M | 375.48M | 394.05M | 291.15M | |
| Invested capital | 0 | 0.01 | 0.05 | 0.07 | 0.07 | |
| Average receivables | 197.5K | 294K | 2.2M | 5.58M | 6.87M | |
| Average payables | 1.66M | 1.41M | 2.95M | 2.95M | 1.74M | |
| Average inventory | 0 | 275.5K | 2.35M | 4.39M | 4.56M | |
| Days sales outstanding | 2.05K | 145.78 | 236.56 | 174.43 | 161.46 | |
| Days payables outstanding | 365 | 0 | 431.51 | 96.68 | 36.41 | |
| Days of inventory on hand | 0 | 0 | 472.05 | 212.62 | 119.36 | |
| Receivables turnover | 0.18 | 2.5 | 1.54 | 2.09 | 2.26 | |
| Payables turnover | 1 | 0 | 0.85 | 3.78 | 10.02 | |
| Inventory turnover | 0 | 0 | 0.77 | 1.72 | 3.06 | |
| ROE | -0.18 | -0.07 | -0.14 | -0.2 | -0.22 | |
| Capex per share | -0.07 | -0.07 | -0.11 | -0.16 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.06 | 0.06 | 0.05 | 0.06 | 0.07 | |
| Net income per share | -0.31 | -0.32 | -0.37 | -0.33 | -0.28 | |
| Operating cash flow per share | -0.23 | -0.3 | -0.24 | -0.23 | -0.16 | |
| Free cash flow per share | -0.31 | -0.31 | -0.26 | -0.29 | -0.19 | |
| Cash per share | 6.71 | 5.54 | 5.02 | 5.18 | 4.93 | |
| Book value per share | 7.12 | 6.81 | 6.56 | 6.35 | 6.19 | |
| Tangible book value per share | 7.12 | 6.81 | 6.56 | 6.35 | 6.19 | |
| Share holders equity per share | 7.12 | 6.81 | 6.56 | 6.35 | 6.19 | |
| Interest debt per share | 0.44 | 0.45 | 0.46 | 0.45 | 0.44 | |
| Market cap | 364.27M | 245.28M | 272.27M | 141.28M | 124.46M | |
| Enterprise value | 340.94M | 226.76M | 245.21M | 133.7M | 120.22M | |
| P/E ratio | -4.61 | -3 | -2.9 | -1.67 | -1.75 | |
| Price to sales ratio | 94.4 | 65.97 | 78.46 | 37.04 | 29.78 | |
| POCF ratio | -25.55 | -12.69 | -17.99 | -9.8 | -12.21 | |
| PFCF ratio | -18.94 | -12.61 | -16.72 | -7.59 | -10.35 | |
| P/B Ratio | 0.81 | 0.57 | 0.65 | 0.35 | 0.31 | |
| PTB ratio | 0.81 | 0.57 | 0.65 | 0.35 | 0.31 | |
| EV to sales | 88.35 | 60.99 | 70.66 | 35.05 | 28.76 | |
| Enterprise value over EBITDA | -15.14 | -8.26 | -9.21 | -5.48 | -5.75 | |
| EV to operating cash flow | -23.92 | -11.73 | -16.2 | -9.28 | -11.8 | |
| EV to free cash flow | -17.73 | -11.66 | -15.06 | -7.18 | -9.99 | |
| Earnings yield | -0.05 | -0.08 | -0.09 | -0.15 | -0.14 | |
| Free cash flow yield | -0.05 | -0.08 | -0.06 | -0.13 | -0.1 | |
| Debt to equity | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Debt to assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Net debt to EBITDA | 1.04 | 0.67 | 1.02 | 0.31 | 0.2 | |
| Current ratio | 34.57 | 31.26 | 21.22 | 27.65 | 25 | |
| Interest coverage | 11.85 | 21.97 | 0 | 0 | 0 | |
| Income quality | 0.63 | 0.81 | 0.65 | 0.68 | 0.57 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 3.27 | 3.89 | 4.08 | 3.47 | 2.29 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.35 | 0.01 | 0.08 | 0.29 | 0.18 | |
| Capex to revenue | -1.29 | -0.03 | -0.33 | -1.1 | -0.44 | |
| Capex to depreciation | -4.51 | -0.1 | -0.88 | -2.91 | -1.16 | |
| Stock based compensation to revenue | 2.11 | 2.35 | 2.81 | 2.19 | 1.82 | |
| Graham number | 7.1 | 7.03 | 7.36 | 6.86 | 6.21 | |
| ROIC | -0.04 | -0.05 | -0.05 | -0.04 | -0.05 | |
| Return on tangible assets | -0.04 | -0.04 | -0.05 | -0.05 | -0.04 | |
| Graham Net | 6.18 | 5.03 | 4.46 | 4.69 | 4.43 | |
| Working capital | 422.4M | 355.62M | 319.58M | 333.6M | 317.29M | |
| Tangible asset value | 446.99M | 432.99M | 418.12M | 405.68M | 396.9M | |
| Net current asset value | 394.05M | 327.58M | 292.31M | 306.95M | 291.15M | |
| Invested capital | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Average receivables | 6.7M | 7.1M | 6.74M | 7.02M | 7.23M | |
| Average payables | 3.04M | 2.03M | 3.6M | 3M | 1.06M | |
| Average inventory | 5.27M | 4.17M | 4.49M | 4.74M | 4.36M | |
| Days sales outstanding | 163.67 | 173.88 | 163.37 | 182.78 | 144.6 | |
| Days payables outstanding | 102.08 | 88.69 | 273.6 | 33.78 | 30.69 | |
| Days of inventory on hand | 224.49 | 168.57 | 274.27 | 189.56 | 100.62 | |
| Receivables turnover | 0.55 | 0.52 | 0.55 | 0.49 | 0.62 | |
| Payables turnover | 0.88 | 1.01 | 0.33 | 2.66 | 2.93 | |
| Inventory turnover | 0.4 | 0.53 | 0.33 | 0.47 | 0.89 | |
| ROE | -0.04 | -0.05 | -0.06 | -0.05 | -0.04 | |
| Capex per share | -0.08 | 0 | -0.02 | -0.07 | -0.03 |
SEER Frequently Asked Questions
What is Seer, Inc. stock symbol ?
Seer, Inc. is a US stock , located in Redwood city of Ca and trading under the symbol SEER
What is Seer, Inc. stock quote today ?
Seer, Inc. stock price is $1.67 today.
Is Seer, Inc. stock public?
Yes, Seer, Inc. is a publicly traded company.
Company Profile
- Volume Average 435.84K
- Market Capitalization 119.18M
- Employee 147
- CEO Dr. Omid C. Farokhzad M.D., Ph.D.
- Headquarters Redwood City,CA,US
- IPO Date 2020-12-04
-
Website
https://seer.bio 
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
